Britta Engelhardt Selected Research

Peptide Hydrolases (Proteases)

10/2023	Compromised Blood-Brain Barrier Junctions Enhance Melanoma Cell Intercalation and Extravasation.
1/2018	Ischemia-reperfusion injury in stroke: impact of the brain barriers and brain immune privilege on neutrophil function.
3/2013	The neurovascular unit as a selective barrier to polymorphonuclear granulocyte (PMN) infiltration into the brain after ischemic injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Britta Engelhardt Research Topics

Disease

34	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 04/2024 - 02/2002
28	Multiple Sclerosis 01/2023 - 02/2002
22	Inflammation (Inflammations) 04/2024 - 08/2002
15	Neuroinflammatory Diseases 01/2023 - 01/2017
6	Relapsing-Remitting Multiple Sclerosis 05/2023 - 01/2008
6	Stroke (Strokes) 12/2018 - 01/2008
5	Infections 01/2023 - 09/2011
5	Autoimmune Diseases (Autoimmune Disease) 09/2020 - 02/2002
3	Progressive Multifocal Leukoencephalopathy 05/2023 - 08/2005
3	Brain Neoplasms (Brain Tumor) 01/2022 - 05/2002
3	Encephalomyelitis (Myeloencephalitis) 09/2020 - 12/2015
3	Edema (Dropsy) 11/2012 - 11/2004
2	Nervous System Diseases (Neurological Disorders) 01/2019 - 01/2008
2	Ischemic Stroke 12/2018 - 01/2018
2	Brain Ischemia (Cerebral Ischemia) 12/2018 - 11/2012
2	Reperfusion Injury 01/2018 - 03/2013
2	Ischemia 03/2013 - 11/2012
2	Alzheimer Disease (Alzheimer's Disease) 09/2011 - 01/2008
2	Crohn Disease (Crohn's Disease) 01/2008 - 08/2005
2	Neoplasms (Cancer) 03/2006 - 03/2005
1	Liver Diseases (Liver Disease) 04/2024
1	COVID-19 10/2023
1	Melanoma (Melanoma, Malignant) 10/2023
1	Cerebral Malaria 01/2023
1	Susac Syndrome 01/2023
1	Mitochondrial Diseases (Mitochondrial Disease) 11/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Disease Progression 04/2021
1	Cognitive Dysfunction 01/2021
1	Narcolepsy 01/2021
1	Enteritis 01/2020

Drug/Important Bio-Agent (IBA)

11	IntegrinsIBA 05/2023 - 01/2003
7	Natalizumab (Tysabri)FDA Link 05/2023 - 08/2005
7	LigandsIBA 09/2020 - 06/2003
6	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 04/2024 - 11/2003
5	ChemokinesIBA 01/2023 - 08/2002
5	Fingolimod Hydrochloride (FTY720)FDA Link 01/2021 - 10/2014
4	Proteins (Proteins, Gene)FDA Link 11/2014 - 01/2005
4	P-SelectinIBA 03/2011 - 06/2003
3	Peptide Hydrolases (Proteases)FDA Link 10/2023 - 03/2013
3	CytokinesIBA 12/2020 - 07/2008
3	AntigensIBA 09/2020 - 03/2011
3	Claudin-3IBA 01/2019 - 06/2003
3	Platelet Endothelial Cell Adhesion Molecule-1IBA 01/2019 - 02/2002
3	Glycoproteins (Glycoprotein)IBA 03/2011 - 06/2003
2	InterleukinsIBA 10/2023 - 05/2009
2	Cell Adhesion MoleculesIBA 01/2023 - 12/2018
2	LipidsIBA 01/2022 - 01/2021
2	EndocannabinoidsIBA 01/2022 - 04/2021
2	Therapeutic UsesIBA 01/2022 - 01/2008
2	Neuroprotective AgentsIBA 01/2022 - 03/2011
2	Junctional Adhesion MoleculesIBA 10/2018 - 01/2012
2	Activated-Leukocyte Cell Adhesion Molecule (Neurolin)IBA 08/2017 - 01/2017
2	7a- (4- octylphenethyl)tetrahydro- 1H- oxazolo(3,4- c)oxazoleIBA 01/2016 - 10/2014
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 12/2015 - 10/2007
2	AgrinIBA 11/2014 - 11/2012
2	Estrogen ReceptorsIBA 09/2011 - 12/2010
2	Estrogens (Estrogen)FDA Link 09/2011 - 12/2010
2	Monoclonal AntibodiesIBA 02/2009 - 01/2008
2	AntibodiesIBA 08/2005 - 11/2004
1	Ferritins (Ferritin)IBA 04/2024
1	Junctional Adhesion Molecule AIBA 04/2024
1	InflammasomesIBA 04/2024
1	RNA (Ribonucleic Acid)IBA 10/2023
1	nitazoxanide (NTZ)FDA Link 05/2023
1	cadherin 5IBA 01/2023
1	PerforinIBA 01/2023
1	Insulin (Novolin)FDA Link 01/2023
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2023
1	HydrogelsIBA 01/2023
1	Interleukin-8 (Interleukin 8)IBA 12/2022
1	Oxidants (Oxidizing Agents)IBA 11/2022
1	ConnexinsIBA 01/2022
1	Glycerol (Glycerine)FDA LinkGeneric 01/2022
1	ProstaglandinsIBA 01/2022
1	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2022
1	Monoacylglycerol LipasesIBA 01/2022
1	Vitamin D FDA LinkGeneric 01/2022
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2022
1	Arachidonic Acid (Vitamin F)IBA 01/2022
1	Histone Deacetylase 1IBA 01/2021
1	lipoxin A4IBA 01/2021
1	piperidineIBA 01/2021
1	Sphingosine-1-Phosphate ReceptorsIBA 01/2021
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2021
1	Histamine H3 Receptors (Histamine H3 Receptor)IBA 01/2021
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2021
1	pitolisantIBA 01/2021
1	MorpholinosIBA 09/2020
1	siponimodIBA 09/2020
1	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2020
1	Adenosine Triphosphate (ATP)IBA 01/2020
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2020
1	teriflunomideIBA 01/2020
1	Cladribine FDA LinkGeneric 01/2020
1	Virulence Factors (Pathogenicity Factors)IBA 01/2020
1	Angiopoietin-2IBA 01/2020

Therapy/Procedure

10	Therapeutics 01/2023 - 01/2008
1	Immunomodulation 01/2022